What we do

PTS is a technology-focused company specializing in the design and manufacturing of nanoparticle delivery systems leveraging our technical expertise in custom polymer, lipid, and polyamino acid synthesis.  PTS’s capabilities support our partner’s therapeutic programs from discovery, clinical development, and product commercialization.

PTS is a leader in the Design, Development & Custom Manufacturing of Drug Substances (DS) and Drug Products (DP) related to advanced drug delivery systems. Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, cGMP Manufacturing and aseptic Fill & Finish.

Services

null

Polyamino Acid Design & Functional Proof of Concept

Our team will provide your team an extensive knowledge on polymer-biology interface to design technologies specially suited for delivering Nucleic Acids, Small Drugs and Proteins.
null

Process Development & Preclinical Batches

Flexible and agile approach to develop robust and reproducible processes to meet your specific product requirements for GLP TOX studies.
null

GMP production & regulatory support

We offer an integral solution to bring your developments from preclinical to GMP manufacturing including our support on regulatory affairs & CMC-DMF documentation.
null

Analytical Development & QC

Our QC scientists support the development of Drug Substances through the entire project life-cycle within GMP & GLP Certified Lab and qualified equipment. Equipment and skills are specially suited but not limited to method development, validation and stability studies.

Testimonials

Ruben Herrendorff
CEO at Polyneuron Pharmaceuticals

PTS has been a very valuable and reliable CMO partner for the past 3 years. The team is very supportive, solution-oriented and dedicated, always willing to go the extra mile to provide excellent results on time. We have been appreciating the tangible long-term vision and value-creating mindset that this company has.

Daniel J. Huang & Michael P. Bevilacqua
Vice President of Operations & M.D., Ph.D. - CEO, CSO, Director & Co-Founder on AMICROBE

PTS has proven itself to be a capable and reliable partner. Over the past two years, we have been repeatedly impressed by their knowledge and professionalism. The PTS team has been both skilled and responsive to our needs, as well as innovative in meeting new challenges. Simply stated, PTS has brought real value to our programs and to our company. We look forward to the next phases of our relationship.

Professor Tim J. Deming
Bioengineering Department - Chemistry and Biochemistry Department at University of California Los Angeles

I have been fortunate to work with PTS on a number of projects where they have been an excellent partner as a CMO and fantastic team members in research and development activities. Having worked in the polypeptide field for more than 25 years, I have seen and been involved with many efforts to commercialize these specialty polymers. In my view, PTS has achieved a depth of understanding and a level of expertise in polypeptide manufacturing and analytics that is second to none. I see PTS as a tremendous asset to the polypeptide community, and highly recommend them as a valuable resource for all polypeptide manufacturing needs

Samaridou Eleni, PostDoctoral Researchar & Jose Crecente, Research Scientist
Dept. of Pharmacy and Pharmaceutical Technology, USC CIMUS Research Institute

Working with PTS on the development of novel polymers for our nanosystems was really profitable. Their expertise in the field of polymer synthesis and characterization enabled us to conduct state-of-the-art research. It is worth mentioning that PTS personnel efficiently supported us with their knowledge at all stage of our collaboration, while timely and successfully completed their tasks. Taking into account everything above, we would be happy to collaborate again with them.

DR. THOMAS BRUCKDORFER
CSO & VP BUSINESS DEVELOPMENT, IRIS BIOTECH GMBH, GERMANY

We have found with PTS a partner, who has profound and deep know-how in both technical aspects of developing and manufacturing real innovative carriers in the field of polymer therapeutics and furthermore a deep understanding for the administrative and documentation necessities in the pharma world. Both is extremely important and valuable, as new developments in the field of biopharmaceuticals require a solid technical understanding from chemistry to pharmacology to biochemistry and  medicinal chemistry, as well as the special regulatory aspects, which have to be matched by any party acting in the health industry.

DR. BEATRIU ESCUDER
ASSOCIATE PROFESSOR, HEAD OF THE BIOSUPRAMAT RESEARCH GROUP

Filling the gap between academia and industry is a big challenge. PTS is an ideal partner for application-oriented academic research in order to transfer fundamental research into the market. PTS research team possess a high level of training in scientific research combined with a privileged vison of the societal needs.

News

Proyecto CDTI: Investigación de una nueva vacuna para una enfermedad respiratoria humana

Hipra Scientific S.L.U, Polypeptide Therapeutic Solutions S.L., Biotechvana S.L. y Nostrum Biodiscovery constituyen el consorcio de empresas que participan en el proyecto “Investigación de una nueva vacuna para una enfermedad respiratoria humana”, subvencionado por el CDTI (Centro para el Desarrollo Tecnológico Industrial), apoyado por el Ministerio de Ciencia e Innovación y financiado por la Unión Europea…

Read more

Polypeptide Therapeutic Solutions and Universiteit Leiden Announce Collaboration to Develop Advanced Polyaminoacid Drug Delivery Systems

Valencia, Spain and Boston, MA, and Leiden, The Netherlands, March 31, 2022 – Polypeptide Therapeutic Solutions (PTS), a leader in the design, development and custom manufacturing of polyamino-acid based delivery systems for therapeutic drugs and the Leiden Academic Centre for Drug Research (LACDR) today announced a research collaboration to develop advanced drug delivery systems for…

Read more

Proyecto FEDER: Ampliación de los sistemas digitales de gestión de diferentes áreas de la empresa de forma centralizada

POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L.U. ha desarrollado con éxito en el ejercicio 2021 un proyecto denominado “Ampliación de los sistemas digitales de gestión de diferentes áreas de la empresa de forma centralizada” (IMDIGA/2021/376), para el que ha contado con el apoyo IVACE y FEDER, a través de su programa de apoyo a “PROYECTOS DE DIGITALIZACIÓN DE…

Read more

Events

Next Generation LNPs

The Next Generation Lipid-Based Nanoparticles Delivery Summit is your definitive industry-led meeting to design and engineer 2nd generation of lipid nanoparticles for emerging payloads beyond RNA into clinic. Join Intellia Therapeutics, Entos Pharmaceuticals, AstraZeneca, Eli Lilly, and other scientific trailblazers as they navigate the next generation of lipid-based nanoparticles for  targeted delivery to expedite innovative treatments for unmet patient needs.

Read more

CRS 2022

The conference theme this year is “Advanced Delivery Science”, which reflects their focus on cutting-edge research and innovation across our strong discipline that will keep you up-to-date with new science and inspire new ideas. Most importantly, this event will offer you the ability to meet in-person for the first time since 2019, to network, form…

Read more

DDF Summit

The 2022 Summit covers small molecules and biologics, new technologies, concepts and case studies in areas such as: Formulation design for poorly soluble compounds The potential of nanotechnology for better deliverability The latest controlled released technologies Improving patient compliance by harnessing data and the latest smart device technology Optimising formulations for continuous manufacturing Overcoming the blood brain barrier and challenges in oral delivery of biologics Reformulation and biosimilars

Read more

11th American DDF Summit (Boston)

  The 2021 Hybrid Summit covers both small molecules and biologics, new technologies, concepts and case studies in areas such as: Formulation design for poorly soluble compounds The potential of nanotechnology for better deliverability The latest controlled released technologies Improving patient compliance by harnessing data and the latest smart device technology Optimising formulations for continuous manufacturing Overcoming the blood brain barrier and challenges in oral delivery of biologics Reformulation and biosimilars   Know moreBook a…

Read more

Partnership Opportunities in Drug Delivery (PODD)

  Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs.   Know moreBook a meeting  

Read more

Contact us

PTS